Patient info

Emcrem cream – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
No longer supplied
Medicine strength:
150 mg/gram + 60 mg/gram
Contains active substances:

Patient leaflet - Emcrem cream

1. WHAT EMCREM IS AND WHAT IT IS USED FOR

Emcrem is an emollient, moisturising and protective cream. It helps to smooth, soothe and hydrate the skin and prevent moisture loss.

Emcrem is used to treat red, inflamed, damaged, dry or chapped skin in adults and children, and to protect raw skin areas. If you suffer from a skin condition called eczema and your skin is dry, the cream can be applied before having a bath to prevent your skin from drying any further. Emcrem can also be used during or after treatment with topical steroid creams, gels or ointments.

2. BEFORE YOU USE EMCREM

Do not use Emcrem:

If you are hypersensitive (allergic) to white soft paraffin, liquid paraffin or any of the other ingredients of

Emcrem. Tell your doctor so that he or she can give you another medicine. Using other medicines:

Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed.

Pregnancy and breast-feeding:

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines:

Emcrem has no influence on the ability to drive and use machines.

Important information about some of the ingredients of Emcrem:

Some of the ingredients in your cream may cause a reaction such as cetostearyl alcohol which may cause a local skin reaction (e.g. contact dermatitis) and chlorocresol which may cause an allergic reaction.

3. HOW TO USE EMCREM

Always use Emcrem exactly as your doctor has instructed you. You should check with your doctor or pharmacist if you are unsure.

Your doctor may have told you when and how often to use the cream and how long to use it for. If so, check the label to remind you what they said. The cream should be thinly applied to cover the affected area completely, massaging gently and thoroughly into the skin as often as is required. If your condition worsens, or your symptoms persist beyond the period of treatment specified by your doctor, you should consult your doctor or pharmacist.

If you have the impression that the effect of Emcrem is too strong or too weak, talk to your doctor or pharmacist. Emcrem is for external use only.

If you forget to use Emcrem:

If you forget to use your cream at the right time, use the usual amount as soon as you remember, then carry on as before.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Emcrem can have side effects although not everybody may get them. If your symptoms persist or the condition worsens, stop using the cream and consult your doctor or pharmacist. Skin reactions including itching, rash, redness, peeling, burning, pain, dryness and skin inflammation (dermatitis) have been reported. If you are worried by this or any other effects, you should tell your doctor or pharmacist.

If any of the side effects become serious or if you experience any side-effects not mentioned in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE EMCREM Keep out of the reach and sight of children.

Do not use Emcrem after the expiry date which is stated on the packaging. The expiry date refers to the last day of that month. Do not store above 25ºC.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. FURTHER INFORMATION

What Emcrem contains:

The active ingredients are white soft paraffin 15%w/w and liquid paraffin 6%w/w. The other ingredients are chlorocresol, macrogol cetostearyl ether, cetostearyl alcohol, dilute phosphoric acid, sodium dihydrogen phosphate and purified water.

What Emcrem looks like and contents of the pack:

Emcrem is a smooth, white cream. It is available in a tube containing 50g and a pump dispenser containing 500g. Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

The holder of the Marketing Authorisation is:

Glenmark Pharmaceuticals Europe Limited

2B Draycott Avenue, Kenton, Middlesex, HA3 0BU, United Kingdom

The manufacturer of Emcrem is: Bioglan AB, Borrgatan 31, 211 24 Malmö, Sweden This leaflet was last revised January 2017 000000

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 25258/0237

Last revision stated in the text: January 2017 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Emcrem cream

Active substances Liquid paraffin, White soft paraffin
Strength 150 mg/gram + 60 mg/gram
Pharmaceutical form Cutaneous cream
A smooth, white to off white cream.
How is it taken Cutaneous
Excipients Macrogol Cetostearyl Ether, Cetostearyl Alcohol, Chlorocresol, Anhydrous Sodium Dihydrogen Phosphate, Dilute Phosphoric acid, Purified water
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 24 Months
Storage Do not store above 25°C
Marketing authorisation PL 25258/0237 (first authorised 16 March 2011)
Marketing authorisation holder Glenmark Pharmaceuticals Europe Limited
Codes BNF 13020100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.